ISDA

Deposition Date 2015-04-21

Release Date 2015-11-25

Last Version Date 2024-03-20

Entry Detail

PDB ID:

4ZFC

Keywords:

OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR

Title:

Crystal structure of AKR1C3 complexed with glicazide

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Host Organism:

Escherichia coli

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.00 Å

R-Value Free:

0.21

R-Value Work:

0.17

R-Value Observed:

0.17

Space Group:

P 1

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Aldo-keto reductase family 1 member C3
Gene (Uniprot):AKR1C3
Chain IDs:A, B
Chain Length:323
Number of Molecules:2
Biological Source:Homo sapiens

UniProt ID:P42330 Pfam ID:PF00248 EC:1.1.1.188

Ligand Molecules

GCZ

NAP

Primary Citation

In vitro inhibition of AKR1Cs by sulphonylureas and the structural basis

Zhao, Y, Zheng, X, Zhang, H, Zhai, J, Zhang, L, Li, C, Zeng, K, Chen, Y, Li, Q, Hu, X.Show

Chem.Biol.Interact. 240 310 315 (2015)

PMID: 26362498 DOI: 10.1016/j.cbi.2015.09.006

Abstact

Recent epidemiological studies show conflicting data for the first-line anti-diabetic sulphonylureas drugs in treating cancer progression in type II diabetes patients. How sulphonylureas promote or diminish tumor growth is not fully understood. Here, we report that seven sulphonylureas exhibit different in vitro inhibition towards AKR1Cs (AKR1C1, AKR1C2, AKR1C3), which are critical steroid hormone metabolism enzymes that are related to prostate cancer, breast cancer and endometrial diseases. Interactions of the sulphonylureas and AKR1Cs were analyzed by X-ray crystallography.

Legend

Protein

Chemical

Disease

Primary Citation of related structures